UK Companies House feature
HUBRX LTD
Cash
£95K
Latest balance sheet
Net assets
-£6M
Equity attributable
Employees
29
Average over period
Profit before tax
-£4M
Period ending 2025-03-31
Profile
- Company number
- 12192691
- Status
- Active
- Incorporation
- 2019-09-06
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 47730
- Hubs
- UK Healthcare
Net assets
7-year trend · vs UK Healthcare median
Accounts
7-year trend · latest 2025-03-31
| Metric | Trend | 2020-09-30 | 2022-03-31 | 2023-03-31 | 2023-04-01 | 2024-03-31 | 2024-04-01 | 2025-03-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £2,967,736 | — | £7,287,229 | |
| Operating profit | — | — | — | — | -£2,305,462 | — | -£3,825,820 | |
| Profit before tax | — | — | — | — | -£2,580,606 | — | -£4,085,224 | |
| Net profit | — | — | — | — | -£2,481,682 | — | -£3,635,445 | |
| Cash | £39,261 | £984,779 | £662,282 | — | £133,855 | — | £94,594 | |
| Total assets less current liabilities | £223,835 | £5,060,118 | £7,499,680 | — | £9,937,755 | — | £15,492,341 | |
| Net assets | £223,835 | -£1,502,974 | £201,611 | — | -£2,280,071 | — | -£5,915,516 | |
| Equity | £223,835 | -£1,502,974 | £201,611 | £201,611 | -£2,280,071 | — | -£5,915,516 | |
| Average employees | 5 | 7 | 10 | — | 19 | — | 29 | |
| Wages | — | — | — | — | £1,042,941 | — | £1,315,790 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Forrester Boyd Robson Limited
- Audit opinion
- Qualified
- Going concern
- Affirmed
“The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. While the Company is still in the development stage the shareholders will fund all requirements. Thus the Company continues to adopt the going concern basis for accounting in preparing the financial statements.”
Subsidiaries
- Pharmacy Plus Health Limited · 1% held · England
- Headingley Projects Limited · 1% held · England
- Missionstart Limited · 1% held · England
- Insightwave Limited · 1% held · England
- Presentornot Limited · 1% held · England
- Averagedream Limited · 1% held · England
- Living Care Limited · 1% held · England
- Living Care Pharmacy Limited · 1% held · England
- Living Care Pharmacy (East Leeds) Limited · 1% held · England
- Living Care Pharmacy (Wakefield) Limited · 1% held · England
- Living Care Pharmacy (South Leeds) Limited · 1% held · England
- Living Care Pharmacy (Chapeltown) Limited · 1% held · England
- Living Care Pharmacy (Ilkley) Limited · 1% held · England
- Living Care Pharmacy (Rockwell) Limited · 1% held · England
- Living Care Pharmacy (Hornsea) Limited · 1% held · England
- Living Care Pharmacy (North Leeds) Limited · 1% held · England
- TPG (Normanton) Ltd · 1% held · England
- TPG (Bramley) Ltd · 1% held · England
- TPG (Tieve Tara) Ltd · 1% held · England
- TPG (Scarborough) Ltd · 1% held · England
- TPG (Flamborough) Ltd · 1% held · England
- TPG (Bridlington) Ltd · 1% held · England
- TPG (LSP) Limited · 1% held · England
- TPG (Oatland) Limited · 1% held · England
- TPG (Trinity) Limited · 1% held · England
- TPG (Dringhouses) Limited · 1% held · England
- TPG (Fulford) Limited · 1% held · England
- TPG (Middleton) Limited · 1% held · England
Significant events
- “Subsequent to the balance sheet date, the Company concluded a formal legal process relating to a claim initiated concerning the acquisition of the pharmacy estate with Pharmacy Plus Health Limited. The legal process was concluded in full on 19 September 2025.”
- “It is considered that a contingent asset has arisen in HubRx Ltd due to the formal derecognition of £654,000 of loan note capital, resulting from a legal process that took place in FY26. The total estimated financial effect is £1,158,640, which also removes any interest accrued. The asset will be recognised once the date of the agreement is certain in FY26.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
7 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| TOLLEFSON, Matthew Thomas | Secretary | 2022-04-26 | — | — |
| LEE, Daniel Mark | Director | 2019-12-16 | May 1970 | British |
| PASSMORE, Sarah, Dr | Director | 2022-06-29 | Oct 1979 | British |
| PEDDER, Mark | Director | 2022-06-29 | Feb 1973 | British |
| TATE, Carl Richard | Director | 2025-04-01 | Nov 1978 | British |
| TOLLEFSON, Matthew Thomas | Director | 2022-02-28 | Oct 1990 | British |
| WOOLDRIDGE, Karl | Director | 2022-06-29 | May 1981 | Irish |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| YORK PLACE COMPANY SECRETARIES LIMITED | Corporate Secretary | 2019-09-06 | 2020-09-09 |
| BEGGS, Howard | Director | 2019-12-29 | 2022-07-21 |
| HEWITSON, Michael Raymond | Director | 2020-05-01 | 2022-07-21 |
| JANKE, Stephanus | Director | 2019-09-06 | 2019-12-16 |
| LESTNER, Jason Elliot | Director | 2023-03-16 | 2024-04-30 |
| RIDDELL, Jennifer May Alice | Director | 2020-03-18 | 2022-07-21 |
| RIDDELL, Sean Douglas | Director | 2019-12-29 | 2022-07-21 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Hubrx Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-07-05 | Active |
| Mr Daniel Mark Lee | Individual | Shares 25–50%, Voting 25–50% | 2019-09-06 | Ceased 2022-07-05 |
Filing timeline
Last 20 of 62 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2026-03-31 | AA | accounts | accounts with accounts type full |
| 2025-09-25 | AP01 | officers | appoint person director company with name date |
| 2025-03-31 | AA | accounts | accounts with accounts type total exemption full |
| 2025-03-27 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-10-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-05-08 | TM01 | officers | termination director company with name termination date |
| 2023-12-30 | AA | accounts | accounts with accounts type total exemption full |
| 2023-09-11 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-05-25 | MR04 | mortgage | mortgage satisfy charge full |
| 2023-05-25 | MR04 | mortgage | mortgage satisfy charge full |
| 2023-04-06 | RESOLUTIONS | resolution | resolution |
| 2023-03-31 | AP01 | officers | appoint person director company with name date |
| 2023-03-29 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-03-28 | SH01 | capital | capital allotment shares |
| 2023-03-21 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2022-12-30 | AA | accounts | accounts with accounts type total exemption full |
| 2022-09-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-07-26 | TM01 | officers | termination director company with name termination date |
| 2022-07-26 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ (private-firm) · reference 2025-03-31
1.77
GREY ZONE
Altman Z″
- Working capital / Total assets 0.449 × 6.56 = +2.94
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets -0.146 × 6.72 = -0.98
- Book equity / Total liabilities -0.184 × 1.05 = -0.19
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory